fda bpc-157 ineligible for compounding 503a 503b BREAKING NEWS! 🚨 An advisory committee just voted 8-6, with one abstention, to recommend adding to the list. Read that carefully, because the comments are about to get What the July 2026 FDA

In the future, we may see peptide therapy become a mainstream option for those seeking safe, effective, and holistic approaches to managing their mental health

Recalls & Warnings April 04, 2012 Maker of Protein Drinks and Supplements Warned of Manufacturing Violations The FDA published a Warning Letter to Protica, Inc., a maker of protein drinks and supplements, regarding violations of manufacturing regulations discovered during inspection of its facility in Whitehall, PA

We do not accept insurance at our offices

Cell Death Differ 15:18571864 Nurdiani R, Vasiljevic T, Singh TK, Donkor ON, Prihanto AA, Kusuma TS (2022) Stability of an anticancer peptide isolated from Flathead by-products during in vitro gastrointestinal digestion